The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity

被引:101
|
作者
Zheng, CJ
Xiang, JL
Hunter, T
Lin, AN [1 ]
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[3] Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.274.41.28966
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Jun N-terminal protein kinase (JNK), a member of the mitogen-activated protein (MAP) kinase family, regulates gene expression in response to various extracellular stimuli. JNK is activated by JNK-activating kinase (JNKK1 and JNKK2), a subfamily of the dual specificity MAP kinase kinase (MEK) family, through phosphorylation on threonine (Thr) 183 and tyrosine (Tyr) 185 residues. The physiological functions of the JNK pathway, however, are not completely understood. A major obstacle is the lack of specific and activated kinase components that: can stimulate the JNK pathway in the absence of any stimulus. Here we show that fusion of JNK1 to its upstream activator JNKK2 resulted in its constitutive activation. In HeLa cells, the JNKK2-JNK1 fusion protein showed significant JNK activity, which was comparable with that of JNK1 activated by many stimuli and activators, including EGF, TNF-alpha, anisomycin, UV irradiation, MEKK1, and small GTP binding proteins Rad and Cdc42Hs. Immunoblotting analysis indicated that JNK1 was phosphorylated by JNKK2 in the fusion protein on both Thr(183) and Tyr(185) residues. Like JNKK2, the JNKK2-JNK1 fusion protein was highly specific for the JNK pathway and did not activate either p38 or ERK2. Transient transfection assays demonstrated that the JNKK2-JNK1 fusion protein was sufficient to stimulate c-Jun transcriptional activity in the absence of any stimulus. Immunofluorescence analysis revealed that the JNKK2-JNK1 fusion protein was predominantly located in the nucleus of transfected HeLa cells. These results indicate that the JNKK2-JNK1 fusion protein is a constitutively active Jun kinase, which will facilitate the investigation of the physiological roles of the JNK pathway.
引用
收藏
页码:28966 / 28971
页数:6
相关论文
共 50 条
  • [21] Insulin stimulates cJun/ATF2 phosphorylation to mediate c-jun transcription via a novel JNK-like kinase
    Ouwens, DM
    Carter, A
    Kooistra, K
    Maassen, JA
    Van Dam, H
    DIABETES, 1999, 48 : A217 - A217
  • [22] c-Jun N-Terminal Kinase (JNK) and c-Jun Mediate Early Migration after Injury in Differentiated Airway Epithelial Cells
    White, S. R.
    Abe, M. K.
    Marroquin, B. A.
    Lascano, D.
    Stern, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [23] Essential roles of c-JUN and c-JUN N-terminal kinase (JNK) in neuregulin-increased expression of the acetylcholine receptor ε-subunit
    Si, JT
    Wang, Q
    Mei, L
    JOURNAL OF NEUROSCIENCE, 1999, 19 (19): : 8498 - 8508
  • [24] TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation
    Zhong, Shuping
    Fromm, Jody
    Johnson, Deborah L.
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) : 54 - 64
  • [25] Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase
    Burgess, GS
    Williamson, EA
    Cripe, LD
    Litz-Jackson, S
    Bhatt, JA
    Stanley, K
    Stewart, MJ
    Kraft, AS
    Nakshatri, H
    Boswell, HS
    BLOOD, 1998, 92 (07) : 2450 - 2460
  • [26] Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors
    Tsuiki, H
    Tnani, M
    Okamoto, I
    Kenyon, LC
    Emlet, DR
    Holgado-Madruga, M
    Lanham, IS
    Joynes, CJ
    Vo, KT
    Wong, AJ
    CANCER RESEARCH, 2003, 63 (01) : 250 - 255
  • [27] MALT1 acts though JNK/c-Jun to promote melanoma growth and metastasis
    Wang, Y.
    Zhang, G.
    Jin, J.
    Degan, S.
    Tameze, Y.
    Zhang, J. Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S111 - S111
  • [28] Transcription of the protein kinase C-δ gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin
    Min, Byong Wook
    Kim, Chang Gun
    Ko, Jesang
    Lim, Yoongho
    Lee, Young Han
    Shin, Soon Young
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2008, 40 (06): : 699 - 708
  • [29] Transcription of the protein kinase C-δ gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin
    Byong Wook Min
    Chang Gun Kim
    Jesang Ko
    Yoongho Lim
    Young Han Lee
    Soon Young Shin
    Experimental & Molecular Medicine, 2008, 40 : 699 - 708
  • [30] c-Jun N Terminal Kinase (JNK) inhibits the activity of the insulin gene promoter.
    Morrison, AA
    Bermano, G
    Ridge, S
    Docherty, K
    DIABETOLOGIA, 2002, 45 : A173 - A173